Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Clinical Lymphoma, Myeloma & Leukemia (2021) 21:785-798. https://doi.org/10.1016/j.clml.2021.06.005
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2024
- Urheber
-
Mateos, Maria-Victoria
Dimopoulos, Meletios A.
Cavo, Michele
Suzuki, Kenshi
Knop, Stefan
Doyen, Chantal
Lucio, Paulo
Nagy, Zsolt
Pour, Ludek
Grosicki, Sebastian
Crepaldi, Andre
Liberati, Anna Marina
Campbell, Philip
Yoon, Sung-Soo
Iosava, Genadi
Fujisaki, Tomoaki
Garg, Mamta
Iida, Shinsuke
Bladé, Joan
Ukropec, Jon
Pei, Huiling
Van Rampelbergh, Rian
Kudva, Anupa
Qi, Ming
San-Miguel, Jesus
- DOI
-
10.1016/j.clml.2021.06.005
- URN
-
urn:nbn:de:bvb:20-opus-370456
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mateos, Maria-Victoria
- Dimopoulos, Meletios A.
- Cavo, Michele
- Suzuki, Kenshi
- Knop, Stefan
- Doyen, Chantal
- Lucio, Paulo
- Nagy, Zsolt
- Pour, Ludek
- Grosicki, Sebastian
- Crepaldi, Andre
- Liberati, Anna Marina
- Campbell, Philip
- Yoon, Sung-Soo
- Iosava, Genadi
- Fujisaki, Tomoaki
- Garg, Mamta
- Iida, Shinsuke
- Bladé, Joan
- Ukropec, Jon
- Pei, Huiling
- Van Rampelbergh, Rian
- Kudva, Anupa
- Qi, Ming
- San-Miguel, Jesus
- Universität Würzburg
Entstanden
- 2024
Ähnliche Objekte (12)
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Impact of patient's frailty and adverse events on the outcome of multiple myeloma
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Geriatric assessments and frailty scores in multiple myeloma patients : : a needed tool for individualized treatment?
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Subgroup growth
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1+ subgroup of multiple myeloma cells for TNF-induced cell death
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Impact of patient's frailty and adverse events on the outcome of multiple myeloma
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Geriatric assessments and frailty scores in multiple myeloma patients : : a needed tool for individualized treatment?
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Subgroup growth
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1+ subgroup of multiple myeloma cells for TNF-induced cell death
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Impact of patient's frailty and adverse events on the outcome of multiple myeloma
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
Geriatric assessments and frailty scores in multiple myeloma patients : : a needed tool for individualized treatment?
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Kinetics of renal function during induction in newly diagnosed multiple myeloma: results of two prospective studies by the German Myeloma Study Group DSMM
Subgroup growth
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence